Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Research finds insecticide danger
Imidacloprid causes impact to bee genes, say scientists

A study has revealed that the genes of honeybees are affected by exposure to neonicotinoid insecticides.

Researchers were able to identify that just two parts per billion of the insecticide imidacloprid was strong enough to impact on the activity of honeybee genes.

The findings follow the European Commission's decision to temporarily ban the use of three neonicotinoids back in April 2013, due to concerns they could be linked to bee deaths.

Dr Reinhard Stöger, an associate professor in epigenetic at the University of Nottingham's School of Biosciences, led the study.

He said: "Although larvae can still grow and develop in the presence of imidacloprid, the stability of the developmental process appears to be compromised."

Dr Stöger also added that, should the bees be exposed to additional stresses, such as pests, disease and bad weather, it is likely to increase the rate of developmental failure.

The results support the European Food Safety Authority's (EFSA) January 2013 report, which deemed imidacloprid an "unacceptable" danger to bees.

Transient Exposure to Low Levels of Insecticide Affects Metabolic Networks of Honeybee Larvae has been published in the Public Library Of Science (PLOS) ONE journal.

The study was funded by the Co-operative Group under its Plan Bee campaign.

Related News

EU takes steps to protect bees
Insecticide danger to bees addressed

 

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
RCVS annual renewal fee for vets due

RCVS' annual renewal fee for veterinary surgeons is now due. Vets must pay their renewal fee before Wednesday, 1 April 2026.

This year's standard annual fee has increased to 431 from last year's 418. This is an approximately three per cent increase, as approved by RCVS Council and the Privy Council.

Tshidi Gardner, RCVS treasurer, said: "The small fee increase will be used to help deliver both our everyday activities and our new ambitious Strategic Plan, which includes aims such as achieving new legislation, reviewing the Codes of Professional Conduct and supporting guidance, and continuing to support the professions through activities such as the Mind Matters Initiative, RCVS Academy and career development."

A full breakdown of the new fees is on the RCVS website. Information about tax relief is available on the UK government website.